Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
DiaMedica Therapeutics Inc. - Common Stock
(NQ:
DMAC
)
7.575
-0.965 (-11.30%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DiaMedica Therapeutics Inc. - Common Stock
DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke
April 17, 2024
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DMAC Stock Earnings: DiaMedica Therapeutics Meets EPS for Q4 2023
↗
March 19, 2024
DMAC stock results show that DiaMedica Therapeutics met analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Recap: DiaMedica Therapeutics Q4 Earnings
↗
March 19, 2024
Via
Benzinga
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results
March 19, 2024
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Announces Poster Presentation at International Stroke Conference
January 29, 2024
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Earnings Outlook For DiaMedica Therapeutics
↗
November 10, 2023
Via
Benzinga
DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer
January 22, 2024
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results
November 13, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Attend the 14th Annual Craig-Hallum Alpha Select Conference November 16, 2023
November 09, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023
November 06, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Earnings Preview: DiaMedica Therapeutics
↗
May 12, 2023
Via
Benzinga
DiaMedica Therapeutics's Earnings Outlook
↗
March 27, 2023
Via
Benzinga
Earnings Scheduled For November 13, 2023
↗
November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
October 25, 2023
Pre-market stock movers are a hot topic on Wednesday and we're offering all the details that investors need to know about this morning.
Via
InvestorPlace
DiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology Officer
September 12, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Participate at Lake Street’s 7th Annual Best Ideas Growth Conference
September 06, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results
August 14, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Report Second Quarter 2023 Financial Results and Provide a Business Update August 15, 2023
August 08, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Attend the American Academy of Neurology Summer Conference
July 18, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Three (3) Stocks Under $10 That Insiders Are Buying
July 05, 2023
These small-cap names provide an opportunity that insiders are buying including deep value, growth, new technology, and AI.
Via
MarketBeat
Topics
Artificial Intelligence
DiaMedica Therapeutics Announces Closing of $37.5 Million Private Placement
June 26, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2023
↗
June 22, 2023
Via
Benzinga
DiaMedica Raises $37.5M Via Equity Offering, Aiding Development Activities For DM199
↗
June 21, 2023
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) has entered into an agreement with accredited investors that have agreed to provide up to $37.5 million in gross proceeds through a
Via
Benzinga
DiaMedica Therapeutics Announces $37.5 Million Private Placement
June 21, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Announces that the FDA Has Removed The Clinical Hold On DM199 Phase 2/3 Trial For Ischemic Stroke
June 21, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Announces Appointment of Dr. Richard Kuntz to the Board of Directors
May 30, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2023 Financial Results
May 15, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Report First Quarter 2023 Financial Results and Provide a Business Update May 16, 2023
May 08, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Appoints David Wambeke as Chief Business Officer
April 11, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2022 Financial Results
March 28, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
